PubMed

Plasma proprotein convertase subtilisin/kexin type 9: a marker of LDL apolipoprotein B-100 catabolism?

Chan DC, Lambert G, Barrett PH, Rye KA, Ooi EM, Watts GF.

Clin Chem. 2009 Nov;55(11):2049-52. Epub 2009 Aug 27.PMID: 19713274 [PubMed - indexed for MEDLINE]Related articles

Regulatory effects of fenofibrate and atorvastatin on lipoprotein A-I and lipoprotein A-I:A-II kinetics in the metabolic syndrome.

Chan DC, Watts GF, Ooi EM, Rye KA, Ji J, Johnson AG, Barrett PH.

Diabetes Care. 2009 Nov;32(11):2111-3. Epub 2009 Aug 3.PMID: 19651918 [PubMed - in process]Related articles

Plasma markers of cholesterol homeostasis in metabolic syndrome subjects with or without type-2 diabetes.

Ooi EM, Ng TW, Chan DC, Watts GF.

Diabetes Res Clin Pract. 2009 Sep;85(3):310-6. Epub 2009 Jul 1.PMID: 19573945 [PubMed - in process]Related articles

Chronic kidney disease delays VLDL apoB-100 particle catabolism: potential role of apo C-III.

Chan DT, Dogra GK, Irish AB, Ooi EM, Barrett PH, Chan DC, Watts GF.

J Lipid Res. 2009 Jun 21. [Epub ahead of print]PMID: 19542564 [PubMed - as supplied by publisher]Related articlesFree article

Therapeutic regulation of apoB100 metabolism in insulin resistance in vivo.

Watts GF, Ooi EM, Chan DC.

Pharmacol Ther. 2009 Sep;123(3):281-91. Epub 2009 May 31. Review.PMID: 19490928 [PubMed - indexed for MEDLINE]Related articles

Very low density lipoprotein metabolism and plasma adiponectin as predictors of high-density lipoprotein apolipoprotein A-I kinetics in obese and nonobese men.

Chan DC, Barrett PH, Ooi EM, Ji J, Chan DT, Watts GF.

J Clin Endocrinol Metab. 2009 Mar;94(3):989-97. Epub 2008 Dec 30.PMID: 19116237 [PubMed - indexed for MEDLINE]Related articles

Nutrition and metabolism: new insights into lifestyle modifications and pharmacotherapy for managing cardiometabolic risk.

Ooi EM, Watts GF.

Curr Opin Lipidol. 2008 Dec;19(6):617-9. No abstract available. PMID: 18957884 [PubMed - indexed for MEDLINE]Related articles

Atorvastatin and fenofibrate have comparable effects on VLDL-apolipoprotein C-III kinetics in men with the metabolic syndrome.

Chan DC, Watts GF, Ooi EM, Ji J, Johnson AG, Barrett PH.

Arterioscler Thromb Vasc Biol. 2008 Oct;28(10):1831-7. Epub 2008 Jun 19.PMID: 18566295 [PubMed - indexed for MEDLINE]Related articlesFree article

Dose-dependent effect of rosuvastatin on VLDL-apolipoprotein C-III kinetics in the metabolic syndrome.

Ooi EM, Watts GF, Chan DC, Chen MM, Nestel PJ, Sviridov D, Barrett PH.

Diabetes Care. 2008 Aug;31(8):1656-61. Epub 2008 May 28.PMID: 18509206 [PubMed - indexed for MEDLINE]Related articlesFree article

Apolipoprotein C-III: understanding an emerging cardiovascular risk factor.

Ooi EM, Barrett PH, Chan DC, Watts GF.

Clin Sci (Lond). 2008 May;114(10):611-24. Review.PMID: 18399797 [PubMed - indexed for MEDLINE]Related articles

An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?

Chan DC, Chen MM, Ooi EM, Watts GF.

Int J Clin Pract. 2008 May;62(5):799-809. Epub 2008 Jan 14. Review.PMID: 18201179 [PubMed - indexed for MEDLINE]Related articles

Dietary plant sterols supplementation does not alter lipoprotein kinetics in men with the metabolic syndrome.

Ooi EM, Watts GF, Barrett PH, Chan DC, Clifton PM, Ji J, Nestel PJ.

Asia Pac J Clin Nutr. 2007;16(4):624-31.PMID: 18042521 [PubMed - indexed for MEDLINE]Related articles

Dose-dependent regulation of high-density lipoprotein metabolism with rosuvastatin in the metabolic syndrome.

Ooi EM, Watts GF, Nestel PJ, Sviridov D, Hoang A, Barrett PH.

J Clin Endocrinol Metab. 2008 Feb;93(2):430-7. Epub 2007 Nov 20.PMID: 18029469 [PubMed - indexed for MEDLINE]Related articlesFree article

Dose-dependent effect of rosuvastatin on apolipoprotein B-100 kinetics in the metabolic syndrome.

Ooi EM, Barrett PH, Chan DC, Nestel PJ, Watts GF.

Atherosclerosis. 2008 Mar;197(1):139-46. Epub 2007 Apr 9.PMID: 17416370 [PubMed - indexed for MEDLINE]Related articles

Plasma phospholipid transfer protein activity, a determinant of HDL kinetics in vivo.

Ooi EM, Watts GF, Ji J, Rye KA, Johnson AG, Chan DC, Barrett PH.

Clin Endocrinol (Oxf). 2006 Dec;65(6):752-9.PMID: 17121526 [PubMed - indexed for MEDLINE]Related articles

Fish oils, phytosterols and weight loss in the regulation of lipoprotein transport in the metabolic syndrome: lessons from stable isotope tracer studies.

Watts GF, Chan DC, Ooi EM, Nestel PJ, Beilin LJ, Barrett PH.

Clin Exp Pharmacol Physiol. 2006 Sep;33(9):877-82. Review.PMID: 16922825 [PubMed - indexed for MEDLINE]Related articles

High-density lipoprotein apolipoprotein A-I kinetics: comparison of radioactive and stable isotope studies.

Ooi EM, Watts GF, Farvid MS, Chan DC, Allen MC, Zilko SR, Barrett PH.

Eur J Clin Invest. 2006 Sep;36(9):626-32.PMID: 16919045 [PubMed - indexed for MEDLINE]Related articles

Relationships between changes in plasma lipid transfer proteins and apolipoprotein B-100 kinetics during fenofibrate treatment in the metabolic syndrome.

Watts GF, Ji J, Chan DC, Ooi EM, Johnson AG, Rye KA, Barrett PH.

Clin Sci (Lond). 2006 Sep;111(3):193-9. Erratum in: Clin Sci (Lond). 2007 Jun;112(12):625. PMID: 16700661 [PubMed - indexed for MEDLINE]Related articles

High-density lipoprotein (HDL) transport in the metabolic syndrome: application of a new model for HDL particle kinetics.

Ji J, Watts GF, Johnson AG, Chan DC, Ooi EM, Rye KA, Serone AP, Barrett PH.

J Clin Endocrinol Metab. 2006 Mar;91(3):973-9. Epub 2005 Dec 20.PMID: 16368749 [PubMed - indexed for MEDLINE]Related articlesFree article

High-density lipoprotein apolipoprotein A-I kinetics in obesity.

Ooi EM, Watts GF, Farvid MS, Chan DC, Allen MC, Zilko SR, Barrett PH.

Obes Res. 2005 Jun;13(6):1008-16.PMID: 15976143 [PubMed - indexed for MEDLINE]Related articles